Timing of Smoking Intervention in Alcohol Treatment (Nicotine Patch)
2 other identifiers
interventional
500
1 country
1
Brief Summary
This study will attempt to determine the best time to begin a smoking cessation program in individuals who undergo intensive treatment for alcohol dependence. The goal of this trial is to determine whether a smoking cessation program is more effective if it occurs at the same time as or after treatment for alcohol dependence. The study also will attempt to determine the effect of smoking cessation programs on the outcome of treatment for alcohol dependence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Sep 1997
Longer than P75 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 1997
CompletedFirst Submitted
Initial submission to the registry
November 2, 1999
CompletedFirst Posted
Study publicly available on registry
November 3, 1999
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2004
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2004
CompletedFebruary 11, 2011
January 1, 2008
6.3 years
November 2, 1999
February 10, 2011
Conditions
Interventions
Eligibility Criteria
You may qualify if:
- Meets criteria for alcohol use disorder and other drug dependence.
- Complete first week of alcohol treatment program.
- Current cigarette smoker (more than 5 cigarettes/day, smoking more than 1 year).
You may not qualify if:
- Lifetime diagnosis of an excluding psychiatric disorder: bipolar disorder, schizophrenia or other psychotic disorder, panic disorder with or without agoraphobia, obsessive-compulsive disorder, generalized anxiety disorder, eating disorder, post- traumatic stress disorder, antisocial personality disorder, or borderline personality disorder.
- Unable to participate in protocol due to functional deficits or severe depression.
- Suicidal or homicidal ideation.
- Current use of disulfiram (Antabuse) or naltrexone (Revia).
- Current use of pipes, cigars, or smokeless tobacco and unwillingness to stop.
- Lives more than 100 miles from alcohol treatment facility.
- No telephone.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
General Internal Medicine, VA Medical Center
Minneapolis, Minnesota, 55417, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Sponsor Type
- FED
Study Record Dates
First Submitted
November 2, 1999
First Posted
November 3, 1999
Study Start
September 1, 1997
Primary Completion
January 1, 2004
Study Completion
January 1, 2004
Last Updated
February 11, 2011
Record last verified: 2008-01